Monique B. Does
Research Subjects
Research Interests
Monique B. Does has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Kelly Corrinne Young-Wolff
Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA
7 shared publications Cynthia I. Campbell
4 shared publications- Sara R. Adams
Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA
4 shared publications - Cynthia I. Campbell
Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA
3 shared publications Deborah Ansley
3 shared publications- Asma H. Asyyed
Regional Offices, Kaiser Permanente Northern California, Pleasanton, CA, USA
2 shared publications
Latest Publications
- 7 June 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 72 (1) , 108477
Behavioral Health and Substance Use Correlates of E-Cigarette Use in Early Pregnancy
- 7 June 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 72 (1) , 108477
Behavioral Health and Substance Use Correlates of E-Cigarette Use in Early Pregnancy
- 1 July 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (6) , 107964
Association of Preconception and Prenatal Cannabis Use With Breastfeeding
- 1 July 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (6) , 107964
Association of Preconception and Prenatal Cannabis Use With Breastfeeding
- Open Access
- 19 March 2025
- Published by Elsevier in Addictive Behaviors Reports
- Vol. 21, 100597
Patterns of substance use and associations with mental health and interpersonal violence among adolescents
- 19 March 2025
- Published by Elsevier in Addictive Behaviors Reports
- Vol. 21, 100597
Open AccessPatterns of substance use and associations with mental health and interpersonal violence among adolescents
- Open Access
- 15 November 2024
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 19 (2) , 179-186
Predictors of Participation in Prenatal Substance Use Assessment, Counseling, and Treatment Among Pregnant Individuals in Prenatal Settings Who Use Cannabis
Objectives: Assessment and counseling are recommended for individuals with prenatal cannabis use. We examined characteristics that predict prenatal substance use assessment and counseling among individuals who screened positive for prenatal cannabis use in prenatal settings. Methods: Electronic health record data from Kaiser Permanente Northern California’s Early Start perinatal substance use screening, assessment, and counseling program was used to identify individuals with ≥1 pregnancies positive for prenatal cannabis use. Outcomes included completion of a substance use assessment and among those assessed, attendance in Early Start counseling only or Addiction Medicine Recovery Services (AMRS) treatment. Predictors included demographics and past-year psychiatric and substance use disorder diagnoses evaluated with GEE multinomial logistic regression. Results: The sample included 17,782 individuals with 20,398 pregnancies positive for cannabis use (1/2011–12/2021). Most pregnancies (80.3%) had an assessment. Individuals with Medicaid, anxiety, depression and tobacco use disorders, compared to those without, had higher odds and those with greater parity, older age (≥35) and in later trimesters, had lower odds of assessment. Among 64% (n = 10,469) pregnancies needing intervention based on assessment, most (88%) attended Early Start counseling only or AMRS (with or without Early Start). Greater parity and later trimester assessment was associated with lower odds, while Medicaid was associated with higher odds of Early Start counseling. Nearly all diagnosed psychiatric and substance use disorders were associated with higher odds of AMRS treatment. Conclusions: A comprehensive prenatal substance use program engaged most pregnant individuals with prenatal cannabis use in substance use assessment and counseling. Opportunities to improve care gaps remain.
- 15 November 2024
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 19 (2) , 179-186
Open AccessPredictors of Participation in Prenatal Substance Use Assessment, Counseling, and Treatment Among Pregnant Individuals in Prenatal Settings Who Use Cannabis
Objectives: Assessment and counseling are recommended for individuals with prenatal cannabis use. We examined characteristics that predict prenatal substance use assessment and counseling among individuals who screened positive for prenatal cannabis use in prenatal settings. Methods: Electronic health record data from Kaiser Permanente Northern California’s Early Start perinatal substance use screening, assessment, and counseling program was used to identify individuals with ≥1 pregnancies positive for prenatal cannabis use. Outcomes included completion of a substance use assessment and among those assessed, attendance in Early Start counseling only or Addiction Medicine Recovery Services (AMRS) treatment. Predictors included demographics and past-year psychiatric and substance use disorder diagnoses evaluated with GEE multinomial logistic regression. Results: The sample included 17,782 individuals with 20,398 pregnancies positive for cannabis use (1/2011–12/2021). Most pregnancies (80.3%) had an assessment. Individuals with Medicaid, anxiety, depression and tobacco use disorders, compared to those without, had higher odds and those with greater parity, older age (≥35) and in later trimesters, had lower odds of assessment. Among 64% (n = 10,469) pregnancies needing intervention based on assessment, most (88%) attended Early Start counseling only or AMRS (with or without Early Start). Greater parity and later trimester assessment was associated with lower odds, while Medicaid was associated with higher odds of Early Start counseling. Nearly all diagnosed psychiatric and substance use disorders were associated with higher odds of AMRS treatment. Conclusions: A comprehensive prenatal substance use program engaged most pregnant individuals with prenatal cannabis use in substance use assessment and counseling. Opportunities to improve care gaps remain.
- 27 April 2024
- Published by Elsevier in Addictive Behaviors
- Vol. 156, 108046
Clinician perspectives on adolescent cannabis-related beliefs and behaviors following recreational cannabis legalization
- 27 April 2024
- Published by Elsevier in Addictive Behaviors
- Vol. 156, 108046
Clinician perspectives on adolescent cannabis-related beliefs and behaviors following recreational cannabis legalization
- Open Access
- 22 January 2024
- Published by Springer Nature in BMC Health Services Research
- Vol. 24 (1) , 1-13
A patient activation intervention in primary care for patients with chronic pain on long term opioid therapy: results from a randomized control trial
Background: Given significant risks associated with long-term prescription opioid use, there is a need for non-pharmacological interventions for treating chronic pain. Activating patients to manage chronic pain has the potential to improve health outcomes. The ACTIVATE study was designed to evaluate the effectiveness of a 4-session patient activation intervention in primary care for patients on long-term opioid therapy. Methods: The two-arm, pragmatic, randomized trial was conducted in two primary care clinics in an integrated health system from June 2015—August 2018. Consenting participants were randomized to the intervention (n = 189) or usual care (n = 187). Participants completed online and interviewer-administered surveys at baseline, 6- and 12- months follow-up. Prescription opioid use was extracted from the EHR. The primary outcome was patient activation assessed by the Patient Activation Measure (PAM). Secondary outcomes included mood, function, overall health, non-pharmacologic pain management strategies, and patient portal use. We conducted a repeated measure analysis and reported between-group differences at 12 months. Results: At 12 months, the intervention and usual care arms had similar PAM scores. However, compared to usual care at 12 months, the intervention arm demonstrated: less moderate/severe depression (odds ratio [OR] = 0.40, 95%CI 0.18–0.87); higher overall health (OR = 3.14, 95%CI 1.64–6.01); greater use of the patient portal’s health/wellness resources (OR = 2.50, 95%CI 1.42–4.40) and lab/immunization history (OR = 2.70, 95%CI 1.29–5.65); and greater use of meditation (OR = 2.72; 95%CI 1.61–4.58) and exercise/physical therapy (OR = 2.24, 95%CI 1.29–3.88). At 12 months, the intervention arm had a higher physical health measure (mean difference 1.63; 95%CI: 0.27–2.98). Conclusion: This trial evaluated the effectiveness of a primary care intervention in improving patient activation and patient-reported outcomes among adults with chronic pain on long-term opioid therapy. Despite a lack of improvement in patient activation, a brief intervention in primary care can improve outcomes such as depression, overall health, non-pharmacologic pain management, and engagement with the health system. Trial Registration: The study was registered on 10/27/14 on ClinicalTrials.gov (NCT02290223).
- 22 January 2024
- Published by Springer Nature in BMC Health Services Research
- Vol. 24 (1) , 1-13
Open AccessA patient activation intervention in primary care for patients with chronic pain on long term opioid therapy: results from a randomized control trial
Background: Given significant risks associated with long-term prescription opioid use, there is a need for non-pharmacological interventions for treating chronic pain. Activating patients to manage chronic pain has the potential to improve health outcomes. The ACTIVATE study was designed to evaluate the effectiveness of a 4-session patient activation intervention in primary care for patients on long-term opioid therapy. Methods: The two-arm, pragmatic, randomized trial was conducted in two primary care clinics in an integrated health system from June 2015—August 2018. Consenting participants were randomized to the intervention (n = 189) or usual care (n = 187). Participants completed online and interviewer-administered surveys at baseline, 6- and 12- months follow-up. Prescription opioid use was extracted from the EHR. The primary outcome was patient activation assessed by the Patient Activation Measure (PAM). Secondary outcomes included mood, function, overall health, non-pharmacologic pain management strategies, and patient portal use. We conducted a repeated measure analysis and reported between-group differences at 12 months. Results: At 12 months, the intervention and usual care arms had similar PAM scores. However, compared to usual care at 12 months, the intervention arm demonstrated: less moderate/severe depression (odds ratio [OR] = 0.40, 95%CI 0.18–0.87); higher overall health (OR = 3.14, 95%CI 1.64–6.01); greater use of the patient portal’s health/wellness resources (OR = 2.50, 95%CI 1.42–4.40) and lab/immunization history (OR = 2.70, 95%CI 1.29–5.65); and greater use of meditation (OR = 2.72; 95%CI 1.61–4.58) and exercise/physical therapy (OR = 2.24, 95%CI 1.29–3.88). At 12 months, the intervention arm had a higher physical health measure (mean difference 1.63; 95%CI: 0.27–2.98). Conclusion: This trial evaluated the effectiveness of a primary care intervention in improving patient activation and patient-reported outcomes among adults with chronic pain on long-term opioid therapy. Despite a lack of improvement in patient activation, a brief intervention in primary care can improve outcomes such as depression, overall health, non-pharmacologic pain management, and engagement with the health system. Trial Registration: The study was registered on 10/27/14 on ClinicalTrials.gov (NCT02290223).
- 24 April 2023
- Published by Alcohol Research Documentation, Inc. in Journal of Studies on Alcohol and Drugs
- Vol. 84 (5) , 723-733
Cannabis use for medical reasons among patients in a large California health care system after legalization of non-medical use
Objective: In 2018, California legalized the sale of cannabis for adult nonmedical use. To understand use of cannabis after legalization, we surveyed a stratified random sample of adults in a large health system (ages 19-64 years) with and without documented chronic pain about their reasons for cannabis use from November 2018 to March 2019. Method: We compared patients with and without chronic pain on measures for medical, nonmedical, pain-related, and mental health-related cannabis use based on self-reported symptoms. Results: Patients with chronic pain reported higher past-year medical use (34.6%) compared to patients without chronic pain (22.8%), past-year pain-related use (29.7% vs. 15.5%), and past-year mental health-related use (24.8% vs. 18.9%). In adjusted models, relative to patients without chronic pain, those with chronic pain had a 6.2% (95% CI [0.010, 0.11]) higher probability of past-year medical cannabis use and an 8.0% (95% CI [0.035, 0.13]) higher probability of past-year pain-related cannabis use. Conclusions: Compared to patients without chronic pain, patients with chronic pain were more likely to use cannabis for reasons related to medical and pain symptoms in the past year. Use for past-year mental health symptoms did not differ between these two groups. Cannabis use among patients with and without chronic pain is common after legalization for nonmedical use, and understanding reasons for use is important to improve overall patient care.
- 24 April 2023
- Published by Alcohol Research Documentation, Inc. in Journal of Studies on Alcohol and Drugs
- Vol. 84 (5) , 723-733
Cannabis use for medical reasons among patients in a large California health care system after legalization of non-medical use
Objective: In 2018, California legalized the sale of cannabis for adult nonmedical use. To understand use of cannabis after legalization, we surveyed a stratified random sample of adults in a large health system (ages 19-64 years) with and without documented chronic pain about their reasons for cannabis use from November 2018 to March 2019. Method: We compared patients with and without chronic pain on measures for medical, nonmedical, pain-related, and mental health-related cannabis use based on self-reported symptoms. Results: Patients with chronic pain reported higher past-year medical use (34.6%) compared to patients without chronic pain (22.8%), past-year pain-related use (29.7% vs. 15.5%), and past-year mental health-related use (24.8% vs. 18.9%). In adjusted models, relative to patients without chronic pain, those with chronic pain had a 6.2% (95% CI [0.010, 0.11]) higher probability of past-year medical cannabis use and an 8.0% (95% CI [0.035, 0.13]) higher probability of past-year pain-related cannabis use. Conclusions: Compared to patients without chronic pain, patients with chronic pain were more likely to use cannabis for reasons related to medical and pain symptoms in the past year. Use for past-year mental health symptoms did not differ between these two groups. Cannabis use among patients with and without chronic pain is common after legalization for nonmedical use, and understanding reasons for use is important to improve overall patient care.
- 13 September 2011
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2011 (1)
TIME TRENDS IN RESIDENTIAL DUST CONCENTRATIONS OF POLYCYCLIC AROMATIC HYDROCARBONS
Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences. Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences.
- 13 September 2011
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2011 (1)
TIME TRENDS IN RESIDENTIAL DUST CONCENTRATIONS OF POLYCYCLIC AROMATIC HYDROCARBONS
Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences. Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences.